{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T07:21:27Z","timestamp":1782631287781,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ME 3696\/6-1"],"award-info":[{"award-number":["ME 3696\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cardiovascular disease is a major morbidity in children after kidney transplantation, limiting life expectancy and impairing graft function. Arterial hypertension is the dominant cardiovascular risk factor and highly abundant in this patient group. Arterial hypertension can cause left ventricular hypertrophy, which is predictive of cardiovascular death. Left ventricular hypertrophy can be non-invasively assessed by measuring left ventricular mass. Observational data indicated that intensified blood pressure control was associated with a significant reduction of left ventricular mass. Based on evidence from the randomized controlled ESCAPE trial, intensified blood pressure control is recommended in children with chronic kidney disease prior to kidney replacement therapy. However, current treatment recommendations for pediatric kidney transplant patients follow the recommendations for otherwise healthy children and adolescents with arterial hypertension, i.e., suggesting a blood pressure target\u2009&lt;\u200990th percentile.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In the proposed multicenter, randomized, parallel group trial with blinded endpoint evaluation, we aim to include 170 pediatric patients who underwent a kidney transplantation more than 12 months ago. Patients will be randomly assigned 1:1 to an intensified blood pressure management group (blood pressure target\u2009\u2264\u200960th percentile) and a standard blood pressure management group (blood pressure target\u2009&lt;\u200990th percentile). The primary endpoint is left ventricular mass after 24 months. Secondary endpoints are pulse wave velocity, intima media thickness, estimated glomerular filtration rate, and albuminuria. Achievement of blood pressure targets will be facilitated through blood pressure telemonitoring. Blood pressure values will be transmitted in real time to the treating physician and the trial\u2019s centralized study office allowing timely responses in case blood pressure values lie outside target range.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>The proposed study will result in an evidence-based definition of blood pressure targets and will therefore have direct implications for the care of children after kidney transplantation. In case intensified blood pressure targets are effective, this should eventually lead to lower cardiovascular morbidity and subsequently lower cardiovascular mortality of pediatric kidney transplant recipients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov NCT06589947. Registered on September 6, 2024.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-09033-z","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:00:39Z","timestamp":1756299639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["StOPping Hypertension and imprOving Children\u2019s Lives after KidnEy TranSplantation (SOPHOCLES): study protocol for a randomized controlled multicenter trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Carl","family":"Grabitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Memaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizky I.","family":"Sugianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine","family":"von der Born","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Bukova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Konuhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Holzwart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Gro\u00dfhennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard M. W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Melk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"5","key":"9033_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.2215\/CJN.04920610","volume":"6","author":"SM Samuel","year":"2011","unstructured":"Samuel SM, Tonelli MA, Foster BJ, Alexander RT, Nettel-Aguirre A, Soo A, et al. Survival in pediatric dialysis and transplant patients. Clin J Am Soc Nephrol. 2011;6(5):1094\u20139. https:\/\/doi.org\/10.2215\/CJN.04920610. Epub 2011\/03\/12. CJN.04920610.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"9033_CR2","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/hypertensionaha.113.01297","volume":"62","author":"A Doyon","year":"2013","unstructured":"Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, et al. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension. 2013;62(3):550\u20136. https:\/\/doi.org\/10.1161\/hypertensionaha.113.01297. Epub 2013\/07\/03.","journal-title":"Hypertension"},{"issue":"12","key":"9033_CR3","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ajh\/hpv048","volume":"28","author":"D Thurn","year":"2015","unstructured":"Thurn D, Doyon A, Sozeri B, Bayazit AK, Canpolat N, Duzova A, et al. Aortic pulse wave velocity in healthy children and adolescents: reference values for the vicorder device and modifying factors. Am J Hypertens. 2015;28(12):1480\u20138. https:\/\/doi.org\/10.1093\/ajh\/hpv048. Epub 2015\/05\/07. hpv048.","journal-title":"Am J Hypertens"},{"issue":"4","key":"9033_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578\u201385. https:\/\/doi.org\/10.1681\/ASN.2011111115. ASN.2011111115.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"9033_CR5","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s00467-021-04928-w","volume":"36","author":"M Bonthuis","year":"2021","unstructured":"Bonthuis M, Vidal E, Bjerre A, Aydog O, Baiko S, Garneata L, et al. Ten-year trends in epidemiology and outcomes of pediatric kidney replacement therapy in Europe: data from the ESPN\/ERA-EDTA Registry. Pediatr Nephrol. 2021;36(8):2337\u201348. https:\/\/doi.org\/10.1007\/s00467-021-04928-w. Epub 2021\/01\/24.","journal-title":"Pediatr Nephrol."},{"issue":"26","key":"9033_CR6","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1056\/NEJMoa031643","volume":"350","author":"SP McDonald","year":"2004","unstructured":"McDonald SP, Craig JC. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350(26):2654\u201362. https:\/\/doi.org\/10.1056\/NEJMoa031643. Epub 2004\/06\/25.","journal-title":"N Engl J Med."},{"issue":"11","key":"9033_CR7","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/ndt\/gfw225","volume":"31","author":"LC Dobrowolski","year":"2016","unstructured":"Dobrowolski LC, van Huis M, van der Lee JH, Peters Sengers H, Lilien MR, Cransberg K, et al. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in the Netherlands. Nephrol Dial Transplant. 2016;31(11):1947\u201356. https:\/\/doi.org\/10.1093\/ndt\/gfw225. Epub 2016\/11\/04.","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"9033_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-019-04395-4","volume":"35","author":"RI Sugianto","year":"2020","unstructured":"Sugianto RI, Schmidt BMW, Memaran N, Duzova A, Topaloglu R, Seeman T, et al. Sex and age as determinants for high blood pressure in pediatric renal transplant recipients: a longitudinal analysis of the certain registry. Pediatr Nephrol. 2020;35(3):415\u201326. https:\/\/doi.org\/10.1007\/s00467-019-04395-4. Epub 2019\/12\/08.","journal-title":"Pediatr Nephrol."},{"issue":"8","key":"9033_CR9","doi-asserted-by":"publisher","first-page":"e13597","DOI":"10.1111\/petr.13597","volume":"23","author":"A Chua","year":"2019","unstructured":"Chua A, Cramer C, Moudgil A, Martz K, Smith J, Blydt-Hansen T, et al. Kidney transplant practice patterns and outcome benchmarks over 30 years: the 2018 report of the NAPRTCS. Pediatr Transplant. 2019;23(8):e13597. https:\/\/doi.org\/10.1111\/petr.13597. Epub 2019\/10\/28.","journal-title":"Pediatr Transplant."},{"issue":"11","key":"9033_CR10","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1097\/TP.0000000000002675","volume":"103","author":"R Blote","year":"2019","unstructured":"Blote R, Memaran N, Borchert-Morlins B, Thurn-Valsassina D, Goldschmidt I, Beier R, et al. Greater susceptibility for metabolic syndrome in pediatric solid organ and stem cell transplant recipients. Transplantation. 2019;103(11):2423\u201333. https:\/\/doi.org\/10.1097\/TP.0000000000002675. Epub 2019\/02\/26.","journal-title":"Transplantation."},{"issue":"7","key":"9033_CR11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/ajh\/hpv192","volume":"29","author":"S Stabouli","year":"2016","unstructured":"Stabouli S, Printza N, Dotis J, Gkogka C, Kollios K, Kotsis V, et al. Long-term changes in blood pressure after pediatric kidney transplantation. Am J Hypertens. 2016;29(7):860\u20135. https:\/\/doi.org\/10.1093\/ajh\/hpv192.","journal-title":"Am J Hypertens"},{"issue":"3","key":"9033_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00467-022-05635-w","volume":"38","author":"S Brar","year":"2023","unstructured":"Brar S, Dixon SN, Paterson JM, Dirk J, Hahn E, Kim SJ, et al. Incidence of cardiovascular disease and mortality in childhood solid organ transplant recipients: a population-based study. Pediatr Nephrol. 2023;38(3):801\u201310. https:\/\/doi.org\/10.1007\/s00467-022-05635-w. Epub 20220718.","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"9033_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/S0022-3476(03)00209-9","volume":"143","author":"MM Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Khoury PR, McEnery PT. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr. 2003;143(1):98\u2013103. https:\/\/doi.org\/10.1016\/S0022-3476(03)00209-9.","journal-title":"J Pediatr"},{"issue":"12","key":"9033_CR14","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071. https:\/\/doi.org\/10.1097\/HJH.0000000000003480. Epub 20230926.","journal-title":"J Hypertens."},{"issue":"2","key":"9033_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.hyp.35.2.580","volume":"35","author":"G Schillaci","year":"2000","unstructured":"Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000;35(2):580\u20136. https:\/\/doi.org\/10.1161\/01.hyp.35.2.580.","journal-title":"Hypertension"},{"issue":"1","key":"9033_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1399-3046.2009.01141.x","volume":"14","author":"AC Wilson","year":"2010","unstructured":"Wilson AC, Greenbaum LA, Barletta GM, Chand D, Lin JJ, Patel HP, et al. High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients. Pediatr Transplant. 2010;14(1):52\u201360. https:\/\/doi.org\/10.1111\/j.1399-3046.2009.01141.x. Epub 2009\/03\/04.","journal-title":"Pediatr Transplant."},{"issue":"11","key":"9033_CR17","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00467-017-3771-8","volume":"32","author":"B Borchert-Morlins","year":"2017","unstructured":"Borchert-Morlins B, Thurn D, Schmidt BMW, Buscher AK, Oh J, Kier T, et al. Factors associated with cardiovascular target organ damage in children after renal transplantation. Pediatr Nephrol. 2017;32(11):2143\u201354. https:\/\/doi.org\/10.1007\/s00467-017-3771-8. Epub 2017\/08\/15.","journal-title":"Pediatr. Nephrol"},{"issue":"3","key":"9033_CR18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/TP.0000000000001948","volume":"102","author":"BMW Schmidt","year":"2018","unstructured":"Schmidt BMW, Sugianto RI, Thurn D, Azukaitis K, Bayazit AK, Canpolat N, et al. Early effects of renal replacement therapy on cardiovascular comorbidity in children with end-stage kidney disease: findings from the 4C-T study. Transplantation. 2018;102(3):484\u201392. https:\/\/doi.org\/10.1097\/TP.0000000000001948. Epub 2017\/09\/20.","journal-title":"Transplantation."},{"issue":"22","key":"9033_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322(22):1561\u20136. https:\/\/doi.org\/10.1056\/NEJM199005313222203.","journal-title":"N Engl J Med"},{"issue":"6","key":"9033_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/HYPERTENSIONAHA.114.03975","volume":"64","author":"M Bombelli","year":"2014","unstructured":"Bombelli M, Facchetti R, Cuspidi C, Villa P, Dozio D, Brambilla G, et al. Prognostic significance of left atrial enlargement in a general population: results of the PAMELA study. Hypertension. 2014;64(6):1205\u201311. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03975. Epub 20140908.","journal-title":"Hypertension."},{"issue":"12","key":"9033_CR21","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/HJH.0b013e328330b845","volume":"27","author":"M Bombelli","year":"2009","unstructured":"Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens. 2009;27(12):2458\u201364. https:\/\/doi.org\/10.1097\/HJH.0b013e328330b845.","journal-title":"J Hypertens"},{"issue":"1","key":"9033_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.110.150128","volume":"56","author":"G de Simone","year":"2010","unstructured":"de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, et al. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010;56(1):99\u2013104. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.150128. Epub 20100524.","journal-title":"Hypertension."},{"issue":"10","key":"9033_CR23","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","volume":"34","author":"E Lurbe","year":"2016","unstructured":"Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887\u2013920. https:\/\/doi.org\/10.1097\/HJH.0000000000001039.","journal-title":"J Hypertens"},{"issue":"17","key":"9033_CR24","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","volume":"361","author":"E Wuhl","year":"2009","unstructured":"Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med. 2009;361(17):1639\u201350. https:\/\/doi.org\/10.1056\/NEJMoa0902066.","journal-title":"N Engl J Med"},{"issue":"9","key":"9033_CR25","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1161\/HYPERTENSIONAHA.123.21187","volume":"80","author":"RI Sugianto","year":"2023","unstructured":"Sugianto RI, Grabitz C, Bayazit A, Duzova A, Thurn-Valsassina D, Memaran N, et al. Stricter blood pressure control is associated with lower left ventricular mass in children after kidney transplantation: a longitudinal analysis of the 4C-T study. Hypertension. 2023;80(9):1900\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.123.21187. Epub 20230718.","journal-title":"Hypertension."},{"issue":"9","key":"9033_CR26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.08791209","volume":"5","author":"U Querfeld","year":"2010","unstructured":"Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol. 2010;5(9):1642\u20138. https:\/\/doi.org\/10.2215\/CJN.08791209.","journal-title":"Clin J Am Soc Nephrol"},{"key":"9033_CR27","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes Blood Pressure Work G. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int.\u00a02021;99(3S):S1-S87. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003.","DOI":"10.1016\/j.kint.2020.11.003"},{"issue":"13","key":"9033_CR28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55(13):1318\u201327. https:\/\/doi.org\/10.1016\/j.jacc.2009.10.061. Epub 2010\/03\/27.","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"9033_CR29","doi-asserted-by":"publisher","first-page":"e0191172","DOI":"10.1371\/journal.pone.0191172","volume":"13","author":"MW Lorenz","year":"2018","unstructured":"Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, et al. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - results from the PROG-IMT collaboration. PLoS One. 2018;13(4):e0191172. https:\/\/doi.org\/10.1371\/journal.pone.0191172. Epub 2018\/04\/13.","journal-title":"PLoS One."},{"issue":"5","key":"9033_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/hypertensionaha.109.192639","volume":"54","author":"EM Urbina","year":"2009","unstructured":"Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009;54(5):919\u201350. https:\/\/doi.org\/10.1161\/hypertensionaha.109.192639. Epub 2009\/09\/05.","journal-title":"Hypertension"},{"issue":"8","key":"9033_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41409-018-0104-x","volume":"53","author":"B Borchert-Morlins","year":"2018","unstructured":"Borchert-Morlins B, Memaran N, Sauer M, Maecker-Kolhoff B, Sykora KW, Blote R, et al. Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age. Bone Marrow Transplant. 2018;53(8):983\u201392. https:\/\/doi.org\/10.1038\/s41409-018-0104-x. Epub 20180209.","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"9033_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/tp.0000000000004025","volume":"106","author":"N Memaran","year":"2022","unstructured":"Memaran N, Onnen M, M\u00fcller C, Schwerk N, Carlens J, Borchert-M\u00f6rlins B, et al. Cardiovascular burden is high in pediatric lung transplant recipients. Transplantation. 2022;106(7):1465\u201372. https:\/\/doi.org\/10.1097\/tp.0000000000004025. Epub 2022\/01\/05.","journal-title":"Transplantation."},{"issue":"5","key":"9033_CR33","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/lt.25431","volume":"25","author":"N Memaran","year":"2019","unstructured":"Memaran N, Borchert-Morlins B, Schmidt BMW, Sugianto RI, Wilke H, Blote R, et al. High burden of subclinical cardiovascular target organ damage after pediatric liver transplantation. Liver Transpl. 2019;25(5):752\u201362. https:\/\/doi.org\/10.1002\/lt.25431. Epub 20190325.","journal-title":"Liver Transpl"},{"issue":"3","key":"9033_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.kint.2021.11.032","volume":"101","author":"RI Sugianto","year":"2022","unstructured":"Sugianto RI, Memaran N, Schmidt BMW, Doyon A, Thurn-Valsassina D, Alpay H, et al. Findings from 4C-T study demonstrate an increased cardiovascular burden in girls with end stage kidney disease and kidney transplantation. Kidney Int. 2022;101(3):585\u201396. https:\/\/doi.org\/10.1016\/j.kint.2021.11.032. Epub 2021\/12\/25.","journal-title":"Kidney Int."},{"issue":"8","key":"9033_CR35","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ajh.2010.80","volume":"23","author":"SD Pierdomenico","year":"2010","unstructured":"Pierdomenico SD, Cuccurullo F. Risk reduction after regression of echocardiographic left ventricular hypertrophy in hypertension: a meta-analysis. Am J Hypertens. 2010;23(8):876\u201381. https:\/\/doi.org\/10.1038\/ajh.2010.80. Epub 20100422.","journal-title":"Am J Hypertens"},{"issue":"10","key":"9033_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/00004872-199510000-00003","volume":"13","author":"ML Muiesan","year":"1995","unstructured":"Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens. 1995;13(10):1091\u20135. https:\/\/doi.org\/10.1097\/00004872-199510000-00003. Epub 1995\/10\/01.","journal-title":"J Hypertens"},{"issue":"19","key":"9033_CR37","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1001\/jama.292.19.2350","volume":"292","author":"RB Devereux","year":"2004","unstructured":"Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292(19):2350\u20136. https:\/\/doi.org\/10.1001\/jama.292.19.2350.","journal-title":"JAMA"},{"issue":"1","key":"9033_CR38","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12882-022-02666-1","volume":"23","author":"KC Maki","year":"2022","unstructured":"Maki KC, Wilcox ML, Dicklin MR, Kakkar R, Davidson MH. Left ventricular mass regression, all-cause and cardiovascular mortality in chronic kidney disease: a meta-analysis. BMC Nephrol. 2022;23(1):34. https:\/\/doi.org\/10.1186\/s12882-022-02666-1. Epub 20220116.","journal-title":"BMC Nephrol."},{"key":"9033_CR39","doi-asserted-by":"publisher","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics.\u00a02017;140(3). https:\/\/doi.org\/10.1542\/peds.2017-1904.","DOI":"10.1542\/peds.2017-1904"},{"issue":"12","key":"9033_CR40","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440\u201363. https:\/\/doi.org\/10.1016\/j.echo.2005.10.005.","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"9033_CR41","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-x","volume":"57","author":"RB Devereux","year":"1986","unstructured":"Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450\u20138. https:\/\/doi.org\/10.1016\/0002-9149(86)90771-x.","journal-title":"Am J Cardiol"},{"key":"9033_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jpeds.2015.10.085","volume":"170","author":"M Chinali","year":"2016","unstructured":"Chinali M, Emma F, Esposito C, Rinelli G, Franceschini A, Doyon A, et al. Left ventricular mass indexing in infants, children, and adolescents: a simplified approach for the identification of left ventricular hypertrophy in clinical practice. J Pediatr. 2016;170:193\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2015.10.085. Epub 2015\/12\/17.","journal-title":"J Pediatr."},{"key":"9033_CR43","doi-asserted-by":"publisher","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004\u20132006\u20132011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc Dis.\u00a02012;34(4):290\u20136. https:\/\/doi.org\/10.1159\/000343145.","DOI":"10.1159\/000343145"},{"issue":"3","key":"9033_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629\u201337. https:\/\/doi.org\/10.1681\/ASN.2008030287.","journal-title":"J Am Soc Nephrol"},{"key":"9033_CR45","doi-asserted-by":"publisher","first-page":"708044","DOI":"10.3389\/fmed.2021.708044","volume":"8","author":"Z Li","year":"2021","unstructured":"Li Z, Duan Y, Zhao M, Magnussen CG, Xi B. Two-year change in blood pressure status and left ventricular mass index in Chinese children. Front Med (Lausanne). 2021;8:708044. https:\/\/doi.org\/10.3389\/fmed.2021.708044. Epub 20210824.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"9033_CR46","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1681\/ASN.2020050645","volume":"32","author":"T Ahlenstiel-Grunow","year":"2021","unstructured":"Ahlenstiel-Grunow T, Liu X, Schild R, Oh J, Taylan C, Weber LT, et al. Steering transplant immunosuppression by measuring virus-specific T cell levels: the randomized, controlled IVIST trial. J Am Soc Nephrol. 2021;32(2):502\u201316. https:\/\/doi.org\/10.1681\/ASN.2020050645. Epub 2020\/12\/17.","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"9033_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ekir.2020.10.011","volume":"6","author":"J Marienne","year":"2021","unstructured":"Marienne J, Laville SM, Caillard P, Batteux B, Gras-Champel V, Masmoudi K, et al. Evaluation of changes over time in the drug burden and medication regimen complexity in esrd patients before and after renal transplantation. Kidney Int Rep. 2021;6(1):128\u201337. https:\/\/doi.org\/10.1016\/j.ekir.2020.10.011. Epub 20201017.","journal-title":"Kidney Int Rep."},{"issue":"7","key":"9033_CR48","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1002\/ejhf.2160","volume":"23","author":"P Gupta","year":"2021","unstructured":"Gupta P, Voors AA, Patel P, Lane D, Anker SD, Cleland JGF, et al. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). Eur J Heart Fail. 2021;23(7):1182\u201390. https:\/\/doi.org\/10.1002\/ejhf.2160. Epub 20210503.","journal-title":"Eur J Heart Fail."},{"key":"9033_CR49","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586. https:\/\/doi.org\/10.1136\/bmj.e7586. Epub 20130108.","journal-title":"BMJ."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09033-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:00:40Z","timestamp":1756299640000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09033-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9033"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09033-z","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study documents have been reviewed and approved by the ethics committee of Hannover Medical School (11188_BO_S_2024). Local institutional review boards are currently involved as required. Aforementioned institutional review boards or ethic committees will be informed on every relevant modifications\/amendments to this protocol. For details on informed consent procedures, please refer to the respective section above.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This protocol does not contain personal data of any individuals. Therefore, consent for publication does not apply.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"315"}}